Nanoparticles in cancer chemotherapy

Progress in Molecular Biology and Translational Science

Volumn 104, Issue , 2011, Pages 489-507

  Banerjee, Deboshri ^a   Sengupta, Shiladitya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer chemotherapy; Drug delivery; Imaging; Nanoparticles; Tumor targeting

Indexed keywords

EID: 81255179352     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416020-0.00012-7     Document Type: Chapter

References (80)

1. American Cancer Society: Cancer facts and figures 2011 2011
2. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 2005 161 171 (Pubitemid 40314948)
3. F. Alexis, E.M. Pridgen, R. Langer, and O.C. Farokhzad M. Scha ferKorting, Drug delivery, handbook of experimental pharmacology 2010 Berlin Heidelberg Springer-Verlag 55 86
4. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat Rev Drug Discov 7 2008 771 782
5. D. Peer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 2007 751
6. S.S. Suri, H. Fenniri, and B. Singh Nanotechnology-based drug delivery systems J Occup Med Toxicol 2 2007 16
7. J.J. Marty, R.C. Oppenheim, and P. Speiser Nanoparticles - a new colloidal drug delivery system Pharm Acta Helv 53 1978 17
8. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
9. R. Langer Drug delivery and targeting Nat Nanotechnol 392 1998 5 10 (Pubitemid 28215187)
10. S.M. Moghimi Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology Anticancer Agents Med Chem 6 2006 553 561
11. D. Bhadra, S. Bhadra, S. Jain, and N.K. Jain A PEGylated dendritic nanoparticle carrier of fluorouracil Int J Pharm 257 2003 111 124 (Pubitemid 36507038)
12. R. Gref 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B Biointerfaces 18 2000 301 313 (Pubitemid 30479870)
13. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical aplications Adv Drug Deliv Rev 55 2003 403 419 (Pubitemid 36293792)
14. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv Drug Deliv Rev 56 2004 1649
15. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv Drug Deliv Rev 60 2008 1615 1626
16. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv Drug Deliv Rev 54 2002 631 651 (Pubitemid 35247520)
17. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm Res 23 2006 1417 1450 (Pubitemid 43993807)
18. R. Satchi-Fainaro Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin Cancer Cell 7 2005 251 261 (Pubitemid 40568684)
19. R. Satchi-Fainaro Targeting Angiogenesis with a conjugate of HPMA copolymer and TNP-470 Nat Med 10 2004 255 261 (Pubitemid 38667615)
20. P. Chaudhuri, R. Harfouche, S. Soni, D.M. Hentschel, and S. Sengupta Shape effect of carbon nanovectors on angiogenesis ACS Nano 4 2010 574 582
21. P. Chaudhuri, A. Paraskar, S. Soni, R.A. Mashelkar, and S. Sengupta Fullerenol-cytotoxic conjugates for cancer chemotherapy ACS Nano 3 2009 2505 2514
22. S. Sengupta Tenporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436 2005 568 572 (Pubitemid 41112931)
23. R. Harfouche Nanoparticle-mediated targeting of phosphatidylinositol-3- kinase signaling inhibits angiogenesis Angiogenesis 12 4 2009 325 338
24. R.K. Jain Barriers to drug delivery in sloid tumors Sci Am 271 1994 58 65
25. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat Rev Cancer 2 2002 48 58 (Pubitemid 37328807)
26. H. Iinuma Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer Int J Cancer 99 2002 130 137 (Pubitemid 34273210)
27. T. Kobayashi Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells Int J Pharm 329 2007 94 102 (Pubitemid 44937528)
28. J.W. Park Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin Cancer Res 8 2002 1172 1181 (Pubitemid 35177372)
29. D.C. Drummond, K. Hong, J.W. Park, C.C. Benz, and D.B. Kirpotin Liposome targeting to tumors using vitamin and growth factor receptors Vitam Horm 60 2000 285 332
30. D.E. Lopes de Menezes, L.M. Pilarski, and T.M. Allen In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma Cancer Res 58 1998 3320 3330 (Pubitemid 28371072)
31. P. Sapra, and T.M. Allen Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res 62 2002 7190 7194 (Pubitemid 36025236)
32. G.P. Adams High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules Cancer Res 61 2001 4750 4755 (Pubitemid 32691886)
33. S. Hong The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem Biol 14 2007 107 115 (Pubitemid 46124068)
34. G. Destito, R. Yeh, C.S. Rae, M.G. Finn, and M. Manchester Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells Chem Biol 14 2007 1152 1162 (Pubitemid 47603227)
35. H.M. Warenius, G. Galfre, N.M. Bleehen, and C. Milstein Attempted targeting of a monoclonal antibody in a human tumour xenograft system Eur J Cancer Clin Oncol 17 1981 1009 1015 (Pubitemid 11017860)
36. M. VonMehren, G.P. Adams, and L.M. Weiner Monoclonal antibody therapy for cancer Annu Rev Med 54 2003 343 369 (Pubitemid 37386401)
37. L.M. Weiner, and G.P. Adams New approaches to antibody therapy Oncogene 19 2000 6144 6151 (Pubitemid 32059465)
38. J. Albanell, and J. Baselga Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer Drugs Today 35 1999 931 946 (Pubitemid 30095596)
39. D. Peer, P. Zhu, C.V. Carman, J. Lieberman, and M. Shimaoka Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 Proc Natl Acad Sci USA 104 2007 4095 4100 (Pubitemid 47181584)
40. M. Crawford, R. Woodman, and F.P. Ko Peptide aptamers: tools for biology and drug discovery Brief Funct Genomic Proteomic 2 2003 72
41. M. Khati The future of aptamers in medicine J Clin Pathol 63 6 2010 480 487
42. J.H. Lee, M.V. Yigit, D. Mazumdar, and Y. Lu Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates Adv Drug Deliv Rev 62 2010 592 605
43. O.C. Farokhzad Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc Natl Acad Sci USA 103 2006 6315 6320
44. J.J. Laskin, and A.B. Sandler Epidermal growth factor receptor inhibitors in lung cancer therapy Semin Respir Crit Care Med 25 Suppl. 1 2004 17 27 (Pubitemid 38857292)
45. R.I. Nicholson, J.M. Gee, and M.E. Harper EGFR and cancer prognosis Eur J Cancer 37 Suppl. 4 2001 S9 S15
46. N.C. Bellocq, S.H. Pun, G.S. Jensen, and M.E. Davis Transferrin- containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery Bioconjug Chem 14 2003 1122 1132 (Pubitemid 37449039)
47. J.F. Kukowska-Latallo Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res 65 2005 5317 5324 (Pubitemid 40827344)
48. A. Buehler cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo Arterioscler Thromb Vasc Biol 26 2006 2681
49. J. Xie, Z. Shen, K.C. Li, and N. Danthi Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle Int J Nanomedicine 2 2007 479
50. J. Schlessinger Cell signaling by receptor tyrosine kinase Cell 103 2000 211 225
51. S. Basu, P. Chaudhuri, and S. Sengupta Targeting oncogenic signaling pathways by exploiting nanotechnology Cell Cycle 8 2009 3480 3487
52. S. Basu Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy Proc Natl Acad Sci USA 106 2009 7957
53. D.P. Cormode, P.A. Jarzyna, W.J. Mulder, and Z.A. Fayad Modified natural nanoparticles as contrast agents for medical imaging Adv Drug Deliv Rev 62 2010 329 338
54. M. Cristofanilli, C. Charnsangavej, and G.N. Hortobagyi Angiogenesis modulation in cancer research: novel clinical approaches Nat Rev Drug Discov 1 2002 415
55. P. Couvreur, B. Kante, M. Roland, and P. Speiser Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum J Pharm Sci 68 1979 1521
56. A. Mitra Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting J Control Release 114 2006 175
57. A. Mitra Targeting tumor angiogenic vasculature using polymer-RGD conjugates J Control Release 102 2005 191
58. E.R. Gillies, and J.M. Frechet Dendrimers and dendritic polymers in drug delivery Drug Discov Today 10 2005 35
59. Y. Xu, Z. Wen, and Z. Xu Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism Anticancer Res 29 2009 5103
60. A.S. Paraskar Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy Proc Natl Acad Sci USA 107 2010 12435 12440
61. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat Rev Drug Discov 4 2005 145
62. D.A. Sipkins Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 1998 623
63. E. Kluza Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis Nano Lett 10 2010 52 58
64. E. Samei Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent Int J Nanomedicine 4 2009 277
65. O. Benny An orally delivered small-molecule formulation with antiangiogenic and anticancer activity Nat Biotechnol 26 2008 799
66. N. Nasongkla Crgd functionalized polymer micelles for targeted doxorubicin delivery Angew Chem Int Ed Engl 43 2004 6323 6327 (Pubitemid 40029462)
67. S. Murugesan, S.A. Mousa, L.J. O'Connor, D.W. Lincoln, and R.J. Linhardt Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis FEBS Lett 581 2007 1157
68. J.R. Mccarthy, K.A. Kelly, E.Y. Sun, and R. Weissleder Targeted delivery of multifunctional magnetic nanoparticles Nanomedicine (Lond) 2 2007 153
69. J.H. Maeng Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer Biomaterials 31 2010 4995 5006
70. J. Drevs PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging Cancer Res 62 2002 4015
71. W. Reichardt, D. Hu-Lowe, D. Torres, R. Weissleder, and A. Bogdanov Jr. Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model Neoplasia 7 2005 847
72. W.J. Mulder Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe Nano Lett 6 2006 1
73. M. Manchester, and P. Singh Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging Adv Drug Deliv Rev 58 2006 1505
74. J.D. Lewis Viral nanoparticles as tools for intravital vascular imaging Nat Med 12 2006 354
75. F.M. Brunel Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting Nano Lett 10 2010 1093 1097
76. C.S. Geninatti Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe Cancer Res 66 2006 9196
77. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J Control Release 121 2007 3 9 (Pubitemid 47126059)
78. Y. Geng Shape effects of filaments vs. spherical particles in flow and drug delivery Nat Nanotechnol 2 2007 249 255 (Pubitemid 46739812)
79. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J Mol Biol 13 1965 238 252
80. J.S. James DOXIL approved by FDA AIDS Patient Care 9 1995 306